Chemoembolization, radioembolization, and other novel intra-arterial therapies

Research output: Chapter in Book/Report/Conference proceedingChapter


Hepatocellular carcinoma (HCC) is a malignancy that arises from aberrant hepatocytes and commonly occurs in the setting of underlying liver disease. The overwhelming majority of patients are precluded from surgical interventions; most patients are either unresectable/nontransplantable by current criteria or inoperable secondary to underlying comorbidities. For patients fortunate enough to undergo operative cure, exceptionally high five-year recurrence rates have been reported (1-4). Without treatment, the prognosis remains dismal and the outcome is uniformly fatal. Although survival depends on many factors, size and stage of tumor at presentation appear to be significant prognosticators of outcome.

Original languageEnglish (US)
Title of host publicationHepatocellular Carcinoma
Subtitle of host publicationA Practical Approach
PublisherCRC Press
Number of pages10
ISBN (Electronic)9780203092880
ISBN (Print)9780415480802
StatePublished - Jan 1 2009

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Chemoembolization, radioembolization, and other novel intra-arterial therapies'. Together they form a unique fingerprint.

Cite this